摘要
复发性流产的病因多种多样,但仍有约50%的复发性流产患者病因不明,称为不明原因复发性流产(URSA),其治疗方法多样,有的存在争议。URSA被认为与母胎免疫耐受失衡有关,近年来关于URSA免疫失衡和治疗的研究是生殖领域的一大热点。本文对国内外URSA的免疫治疗方法进行综述,旨在为临床治疗提供参考。
Various causes have been found to contribute to the pathogenesis of recurrent spontaneous abortion(RSA).Still about 50% of the RSA cases have no known etiology and are considered as unexplained recurrent spontaneous abortion(URSA).Though may treatments have been for URSA,but some of them remain controversial.URSA has been assumed to be caused by a defect in maternal immunological tolerance to the fetus,so researches on the immune disturbance and immunomodulatory treatments for URSA have become a hot topic in the field of reproduction recently.Evaluation of the therapeutic strategies for URSA in this review aims at providing evidence for facilitating clinical therapy.
作者
吴培莉
薛晴
杨慧霞
WU Peili;XUE Qing;YANG Huixia(The First Hospital of Peking University, Beijing, 100034)
出处
《中国计划生育学杂志》
2018年第12期1259-1264,共6页
Chinese Journal of Family Planning
基金
国家重大科学研究计划(2015CB943300)
国家自然科学基金重大项目(81490745)
关键词
不明原因复发性流产
免疫治疗
T淋巴细胞亚群
Unexplained recurrent spontaneous abortion
Immunomodulatory treatment
Th1/Th2/Th17/Treg cell